Triton Distribution Systems, Inc., announces strategic partnership with Hemjoba Inc., and provides corporate update

WINNETKA, Calif., April 24, 2014 /PRNewswire/ -- Triton Distribution Systems, Inc. (OTC Pink: TTDZ) ("Triton") announced today the entry into a strategic partnership with Hemjoba, Inc., a California corporation that produces and retails blended formulas of Jojoba oil and cold-extracted Cannabis oils. Additionally, Triton provided updates on certain corporate events.

Hemjoba Partnership

Since 2009, Hemjoba has strived to provide to the general public medical cannabis products, which do not have the euphoria and mind altering properties that have stigmatized the cannabis plant as a "Gateway Drug." The strategic partnership between Triton and Hemjoba will allow Allbotanical.com to become the exclusive on-line retailer of Hemjoba Pain Relieving Lotion and Hemjoba Omega XL H3O topical healing oil. At the same time, and with the assistance of Richard Brumfield, Founder of Hemjoba, Triton plans to develop additional product concepts for the brand Green Magic, and explore additional medicinal product concepts to be added to the brand Green Cures, which will be introduced to the public throughout 2014.

"Our primary goal is to offer a wide range of products through our first online e-commerce platform Allbotanical.com, which features products that do not require any medical prescription or recommendation," said Triton's CEO Robert Calkin. The Company's initial strategy of producing an immediate generating income resource will bring a platform (Allbotanical.com) that offers numerous hemp-based nutritional and body care products, as well as safe alternatives to narcotic medications with formulations of cold-extracted Cannabis oils (Hemp and Sativa), which omits the THC or the cannabinoids that produce the "high" associated with Cannabis (marijuana).

Corporate Updates

In addition, the Company announced to the public and the investment community that management anticipates that Allbotanical.com will start processing orders within the next 5 business days.  Currently, the Company is finalizing imaging applications and details about its logistics department to ensure that all customers receive their orders through an expedited mail delivery system.

The Company also announced to the public and the investment community that it has submitted the Company's Annual Report for the year ending December 31, 2013, along with other required disclosures, to the OTC Markets website.

Finally, the Company announced to the investment community that in connection with the Company's efforts to change the name of the Company, management anticipates receiving stamped Articles of Incorporation from the time that the company began using its current name, Triton Distribution Systems Inc., from the state of Colorado within the upcoming week.  This document is required to submit a completed application to request the change of company's name to FINRA, with the assistance of the Company's legal counsel and professional advisors.

In closing, management of the Company anticipates that the Company will provide additional updates to the public and the investment community when material events and information becomes available.

About Triton Distribution Systems Inc.: www.greencuresinc.com Triton operates a diverse portfolio of services and products within the botanical industry and medical cannabis industry, as permitted by law. The products include nutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty. In this rapidly growing industry of alternative care and medicinal products, Triton Distribution Systems Inc. also provides to the online community portals that supply with information and resources regarding the benefits of cannabis-derived products..

About Hemjoba Inc: www.buyhemjoba.com Hemjoba Inc. Since 2009 Hemjoba has provided medical cannabis products to the general public without the euphoria and mind altering properties that have stigmatized the cannabis plant as a "Gateway Drug". The company's goal is to provide products that offer a safe alternative to narcotic medications that have become an epidemic of dependency and addiction over the last 25 years.

FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as "scheduled (future sense)" "intend(s)", "plan(s)" "expect(s)", "believe(s)" "will" "estimate(s)", "forecast", "anticipate(s)", "expect(s)", "may", "should", "goal", "target", "aim", "may", "would", "could" or "should" or, in each case, the negative thereof, other variations thereon, comparable terminology or wording/graphical information that implies anticipated future results or deliverables. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, progress of products development, acceptance of products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, and intellectual property rights. You are cautioned not to place any undue reliance on any forward-looking statement, and Triton expressly disclaims any obligation or intention to update any forward-looking statement.

SOURCE Triton Distribution Systems, Inc.